The Role of Biomarkers In Medicine

In medicine, a biomarker is a calculable sign of the severity or presence of some disease state. Further mostly, a biomarker is anything that can be used as a sign of a particular disease state or some other physiological state of an organism.

A biomarker is a measurable indicator of some biological condition or condition. The biomarker can be measured objectively and consistently. Biomarkers play an important role in clinical medicine today. The biomarker allows doctors to detect diseases, predict their course and the effectiveness of treatment. An example of a biomarker commonly used in medicine is prostate-specific antigen (PSA). The search for more profitable and measurable biomarkers continues to drive the pharmaceutical industry. The more biomarkers doctors have in their toolbox, the closer we get to precision medicine.

The use of biomarkers in basic and clinical research has become a routine in many areas of medicine. They are established as molecular signatures that have been well considered and have repeatedly been shown to be capable of predicting relevant disease states or clinical outcomes. In the role of biomarkers in medicine, expert researchers in their individual field have reviewed many biomarkers or potential biomarkers in various types of diseases.

The topics discourse many aspects of medicine, representative the current conceptual status of biomarkers as clinical tools and as substitute endpoints in clinical research. 

Biomarkers are used to

•          Predict the response to a treatment
•          Determine treatment efficacy
•          Confirm the stage of a disease
•          Monitor Progression/recurrence
•          Monitor treatment compliance

Biomarkers can be classified into 3 types

•          Natural History markers
•          Drug activity biomarkers
•          Surrogate Markers

It’s our honor and privilege to invite you to participate at International Conference on Biomarkers and Clinical Research going to be held at Abu Dhabi, UAE during July 15-16, 2019. I hope you can join us for this event. If you are unable to attend, I encourage you to appoint someone as your proxy, colleagues and students to attend the event on your behalf

Types of Biomarkers in Cancer Detection

There are several types of biomarkers, which succeed in different roles across the scale of care. By analyzing biomarkers, diagnostic tests may be able to provide information about early tumor development to detect breast cancer at an early, more curable stage. These biomarkers can be helpful in dealing with patients in the following settings:

 Risk Assessment

These biomarkers are repeatedly associated with a predilection to cancer and can inform a woman's future risk of emerging breast cancer. Healthcare providers often recommend that individuals with these gene mutations reflect more frequent screenings in a crack to detect breast cancer at an early stage.

Screening/Detection

Biomarkers for screening and discovery are real-time indicators of the presence of cancer. The body may reply to the presence of a tumor by generating and releasing immune factors (such as antibodies) or by shedding serum proteins, socializing tumor cells and DNA fragments into the bloodstream.

Diagnosis

Though the only way to approve a breast cancer analysis is by biopsy, biomarkers can aid in diagnosis and help determine the primary origin of the tumor.

Prognosis

Prognostic biomarkers may provide info about a patient's estimated outcome, regardless of therapy.

Some breast cancers are more destructive than others and biomarkers can help control which cancers may grow rapidly and/or metastasize.

Prediction

Biomarkers may be used to predict a patient's reaction to cure or to determine the optimal drug dose or type used for breast cancer treatment. Since breast cancer is a heterogeneous disease, different cancers can answer differently to the same cure methods.

Monitoring

Biomarkers may be used to expect and monitor a patient's breast cancer reappearance of the disease after treatment.

By using diverse types of biomarkers in cancer recognition that are exactly geared towards breast cancer, another biological vision of current disease state is existing in addition to the anatomical view of breast imaging. Categories of cancer biomarkers are capable of detecting, predicting and diagnosing disease. These biomarkers can also support modified prognosis and treatment strategies as well as frequent monitoring for the disease.

Few most promising experimental cancer treatments

Cancer is a collection of diseases having abnormal cell growth with the potential to enter or spread to other parts of the body. These separations with benign tumors, which do not spread to other parts of the body.

Cancer states to the irregular growth of cell tissue. Tumours are generally divided into benign and malignant. A benign tumour is localised, matures gradually and does not frequently result in the patient’s death. Malignant or cancerous tumours grow more quickly. They are not localised and are often disastrous for the patient.

Every year about new advances in oncology research and cancer treatments. Inappropriately a lot of these experimental treatments take years to develop and to run them complete the required clinical trials and they still don’t always pan out in the end. In this few treatments list, however, is going to walk you over some of the most stimulating new cancer treatments currently being tested in pre-clinical trials. Researchers are the most hopeful about these experimental cancer treatments right now and explain why they might be feasible options for cancer patients. Various treatments are still in the early stages of growth, whereas others are currently in pre-clinical and clinical trials to test how feasible they are as treatments.

RADIATION THERAPIES

Radiation therapies are any quantity of therapies that develop different forms of energy to try and cause cancerous tumors to go into reduction.

HYPERTHERMIA THERAPY

Hyperthermia Therapy is an experimental form of cancer therapy that consumes contained or whole-body management of heat. Hyperthermia Therapy is very exciting because, if it turns out to be a viable action, this will destroy the cancerous tumors from the inside out and hinder its ability to infect more healthy cells. This treatment category is now in the very early stages of development, as scientists need to dial in how much heat is needed to destroy these cells.

DRUG THERAPIES

Treatments that decrease under the drug therapies set involve using man-made or natural drugs to encourage cancer recovery.

• DICHLOROACETATE
• QUERCETIN
• COMBINATION OPDIVO AND YERVOY

 BACTERIAL THERAPIES AND VIROTHERAPY

Clostridium Novyi

Scientists have been spending anaerobic bacteria, such as Clostridium Novyi, to consume the interior of oxygen-poor tumors in patients. Clostridium Novyi can grow in oxygen-poor tumors. This is chief because tumor-induced tissue hypoxia can cause even more difficulties than a normal tumor would. Hypoxia exists when tissue is receiving less oxygen than what it needs, causing the body to have an even harder time fighting off infections, cancerous cells and can cause necropsy of tissue.

Clostridium Sporogenesis also being examined as a vehicle for delivering cancer-treating drugs into tumors in patients. Researchers hope to continue emerging and researching this anaerobic bacterium for new cancer-treatment vectors in an effort to kill off hypoxic tumors in patients.

These Experimental cancer treatments are medical treatments deliberate to increase, enhancement or replace traditional cancer treatments (surgery, chemotherapy and radiation) in an attempt to reduce or remove cancerous growths. As you can see, all of the listed treatments are very exciting in nature and, if they become feasible, can hopefully help us eradicate cancer.